Venous malformations are among the most common vascular anomalies, appearing as bluish or purple marks on the skin or deep within body tissues. Understanding how these conditions are managed—from standard therapies to cutting-edge clinical trial approaches—can help patients and families navigate treatment options and expectations.

Understanding Treatment Goals and Approaches for Venous Malformations

When a child or adult receives a diagnosis of venous malformation, the focus of treatment shifts toward practical goals that improve daily life. The primary aims include reducing pain, managing swelling, preventing complications like blood clots, and addressing cosmetic concerns that may affect emotional well-being. Treatment decisions depend heavily on the size and location of the malformation, the patient’s age, and whether symptoms are interfering with essential functions such as breathing, vision, or movement^[1].

Unlike some conditions that follow a one-size-fits-all protocol, venous malformations require individualized care plans. A small, painless lesion on the arm might only need monitoring, while a large malformation affecting the face or internal organs may demand multiple interventions over time. The complexity of these vascular anomalies means that treatment often extends across a patient’s lifetime, with adjustments made as the body grows or as symptoms change^[2].

Medical teams typically distinguish between conservative approaches—such as compression garments and pain management—and more invasive procedures like sclerotherapy (injection of a solution to shrink the malformation) or surgical removal. Both standard treatments approved by medical societies and investigational therapies tested in clinical trials play important roles in modern care. Research continues to explore new molecules and techniques that might offer better outcomes or fewer side effects than current options^[6].

Standard Treatment Methods for Venous Malformations

Conservative management forms the foundation of care for many patients with venous malformations. Compression therapy involves wearing specially fitted garments—typically stockings for the arms or legs—that apply steady pressure to reduce swelling and slow the growth of the malformation. These garments are usually worn during the day and removed at night. For adults, compression class 2 (which applies 25 to 40 mmHg of pressure) strikes a balance between effectiveness and comfort, though some patients benefit from stronger or lighter compression depending on their individual needs^[18].

Compression is particularly helpful for malformations located just beneath the skin. When worn consistently, these garments can prevent the veins from stretching further and help manage discomfort. Because the elastic material loses its effectiveness over time, patients typically need replacement garments every six months. For children, adjustments are necessary as they grow. Proper skin care with moisturizing creams is essential to prevent dryness and irritation under the compression material^[18].

For visible malformations on the face or neck, cosmetic camouflage using water-resistant makeup can significantly improve quality of life. Trained specialists teach patients techniques to apply concealing creams that mask the bluish or purple discoloration. This approach does not treat the underlying condition but addresses the psychological and social impact of having a visible difference^[18].

Pain management is another cornerstone of conservative care. Non-steroidal anti-inflammatory drugs (NSAIDs) can reduce discomfort caused by blood clots forming within the abnormal veins. These medications also have the added benefit of decreasing the tendency of blood to clot, which is a common problem in venous malformations because blood flows very slowly through the enlarged, tangled vessels^[3].

When conservative measures are insufficient, sclerotherapy becomes the primary invasive treatment option. This procedure involves injecting a specialized solution directly into the abnormal veins. The solution irritates the vessel walls, causing them to stick together and close off. Over time, the body reabsorbs the treated tissue. Sclerotherapy can be performed as an outpatient procedure, though larger malformations may require multiple sessions spaced weeks or months apart. The choice of sclerosing agent and the technique used depend on the size, location, and characteristics of the malformation^[5].

Imaging guidance is critical during sclerotherapy. Physicians use ultrasound or fluoroscopy (a type of real-time X-ray) to visualize the abnormal vessels and guide the needle to the right location. This precision helps maximize the treatment’s effectiveness while minimizing damage to surrounding healthy tissue. After the procedure, patients may experience swelling, bruising, and discomfort for several days. Compression garments are typically worn afterward to help maintain the closure of the treated vessels^[9].

Surgical removal is generally reserved for cases where sclerotherapy has failed or is not feasible. Complete surgical excision is rarely possible because venous malformations often extend deeply into muscles, bones, or organs. Surgery may be considered when a malformation is causing severe pain, functional impairment (such as difficulty walking or using a hand), or when there is risk of serious bleeding. In some situations, surgeons perform partial removal to reduce the size of the malformation, followed by sclerotherapy or other treatments to manage what remains^[1].

For superficial skin lesions, laser therapy offers another treatment avenue. Lasers work by targeting the blood within the abnormal vessels, heating and destroying them without requiring incisions. Different types of lasers are used depending on the depth and color of the malformation. Pulsed dye lasers are commonly used for more superficial lesions, while other laser types may be effective for deeper tissues. Multiple treatment sessions are usually necessary, and results vary widely depending on the individual characteristics of the malformation^[19].

Throughout treatment, monitoring for complications is essential. Patients with extensive venous malformations are at risk for developing localized intravascular coagulopathy, a clotting disorder where blood clots form within the malformation and consume clotting factors, potentially leading to dangerous bleeding elsewhere in the body. Blood tests measuring prothrombin time (PT), partial thromboplastin time (PTT), fibrinogen, and D-dimer help physicians assess the severity of this condition. When abnormalities are detected, consultation with a hematologist is usually recommended^[3].

Treatment Approaches in Clinical Trials

While standard treatments provide benefit for many patients, researchers are actively investigating new therapies that target the underlying genetic and molecular causes of venous malformations. Understanding these innovative approaches can help patients consider whether participation in clinical trials might be appropriate for their situation.

Recent scientific discoveries have revealed that most venous malformations arise from genetic mutations in specific cellular pathways. The most commonly affected pathway involves genes called TEK (also known as TIE2) and PIK3CA. These genes produce proteins that regulate how blood vessel cells grow and organize. When mutations occur, cells receive incorrect signals that lead to the formation of abnormal, dilated veins. This knowledge has opened doors to developing drugs that specifically target these faulty molecular signals^[9].

One promising area of clinical research focuses on mTOR inhibitors, a class of drugs that block a protein complex called mammalian target of rapamycin. Since the PIK3CA mutation leads to overactivation of the PI3K-AKT-mTOR pathway, drugs that inhibit mTOR may slow or reduce the growth of venous malformations. Sirolimus (also called rapamycin) is an mTOR inhibitor originally developed to prevent organ transplant rejection. Small studies and case reports have shown that some patients with venous malformations experience reduction in pain, swelling, and malformation size when treated with sirolimus^[9].

Clinical trials are evaluating sirolimus in both oral and topical forms. Oral sirolimus is taken daily as a pill or liquid, with the dose adjusted based on blood levels to balance effectiveness against side effects. Common side effects include mouth ulcers, increased susceptibility to infections, changes in blood counts, and elevated cholesterol levels. Because sirolimus suppresses the immune system, patients need regular monitoring through blood tests. Topical sirolimus gel is being studied for superficial venous malformations, potentially offering benefits with fewer systemic side effects^[9].

Another investigational approach involves drugs that specifically target the PI3K enzyme itself. These agents, called PI3K inhibitors, are designed to be more precise than mTOR inhibitors, potentially offering better efficacy or fewer side effects. Several PI3K inhibitors are in various stages of clinical development for vascular malformations, though most are still in early-phase trials focused on safety and dosing. These medications are taken orally on a daily basis, and researchers are working to understand which patients are most likely to benefit from this approach^[9].

Researchers are also exploring whether existing cancer drugs might be repurposed for treating venous malformations. Since some of the genetic mutations found in venous malformations are similar to those in certain cancers, medications already approved for cancer treatment might prove effective. This strategy has the advantage of faster development timelines since the safety profiles of these drugs are already known from their use in oncology^[9].

Clinical trials for venous malformations typically proceed through several phases. Phase I trials focus primarily on safety, determining the appropriate dose range and identifying potential side effects in a small group of patients. Phase II trials expand to larger groups to assess whether the treatment actually improves symptoms or reduces malformation size. Phase III trials compare the new treatment directly against current standard therapies or placebo to definitively establish effectiveness. Not all experimental treatments progress through all phases—many are discontinued if they prove ineffective or cause unacceptable side effects^[6].

Eligibility for clinical trials varies depending on the specific study. Common requirements include having a confirmed diagnosis of venous malformation (usually verified through imaging such as MRI or ultrasound), experiencing symptoms that affect quality of life, and being willing to undergo regular monitoring visits. Some trials focus specifically on children, while others enroll adults or both age groups. Trials may be conducted at specialized vascular anomalies centers in various geographic locations, including the United States, Europe, and other regions^[8].

Beyond pharmaceutical interventions, clinical researchers are investigating improvements to existing procedural techniques. Advanced imaging methods during sclerotherapy, such as cone-beam computed tomography, allow physicians to visualize the three-dimensional structure of malformations in real time during treatment. This enhanced visualization may lead to more complete treatment with fewer sessions. Studies are comparing different sclerosing agents and injection techniques to determine which approaches provide the best balance of effectiveness and safety^[9].

Some research centers are exploring combination approaches that pair sclerotherapy with medications like sirolimus, hypothesizing that targeting the malformation through multiple mechanisms simultaneously might improve outcomes. Early results from these studies are gradually becoming available, though definitive conclusions about optimal combination strategies remain years away^[9].

Most common treatment methods

• Conservative management
  • Compression garments (stockings or sleeves) worn during the day to reduce swelling and slow malformation growth, particularly effective for limb involvement
  • Cosmetic camouflage using specialized water-resistant makeup to conceal visible discoloration on face and neck
  • Non-steroidal anti-inflammatory drugs (NSAIDs) for pain relief and to reduce clotting tendency
  • Elevation and cooling of affected areas to reduce congestion symptoms
  • Physical therapy and positioning exercises to maintain function and comfort
• Sclerotherapy
  • Injection of specialized solutions directly into abnormal veins to cause them to close and shrink
  • Performed under ultrasound or fluoroscopy guidance for precision
  • Multiple treatment sessions typically required, spaced weeks to months apart
  • Different sclerosing agents selected based on malformation characteristics
  • Compression worn after procedure to maintain vessel closure
• Surgical excision
  • Reserved for cases where sclerotherapy has failed or is not feasible
  • Complete removal rarely possible due to deep tissue involvement
  • May be performed partially to reduce malformation size, followed by other treatments
  • Considered when severe pain, functional impairment, or bleeding risk present
• Laser therapy
  • Pulsed dye lasers commonly used for superficial skin lesions
  • Other laser types (alexandrite) for deeper vascular malformations
  • Multiple treatment sessions usually necessary
  • Works by targeting blood within abnormal vessels to destroy them
• Medical therapy (investigational)
  • mTOR inhibitors like sirolimus (rapamycin) to slow malformation growth
  • PI3K inhibitors targeting specific molecular pathways
  • Both oral and topical formulations under study
  • Primarily available through clinical trials
  • Require regular monitoring for side effects and effectiveness
• Interventional radiology procedures
  • Embolization to block blood flow to certain types of malformations
  • Advanced imaging guidance for more precise treatment delivery
  • Minimally invasive techniques performed by specialized radiologists

Living with Venous Malformations: Long-term Management Considerations

Because venous malformations are lifelong conditions, patients and families benefit from understanding how to manage symptoms day-to-day and recognize when medical attention is needed. Changes in the malformation’s appearance or symptoms can occur during periods of rapid growth (such as puberty), hormonal changes (including pregnancy or menopause), or following injury or infection. Being aware of these potential triggers helps patients prepare for fluctuations in their condition^[2].

Regular follow-up with a specialized vascular anomalies team is important even when symptoms are stable. These appointments allow physicians to monitor for complications such as worsening clotting problems, assess whether current treatments remain effective, and adjust management strategies as needed. Imaging studies like ultrasound or MRI may be repeated periodically to document changes in the malformation’s size or characteristics^[3].

Psychological support can be valuable, especially for children and adolescents dealing with visible malformations or functional limitations. Support groups connecting patients with similar conditions provide opportunities to share experiences and coping strategies. Some treatment centers offer comprehensive care that includes access to mental health professionals familiar with the challenges of living with vascular anomalies^[8].

Education about the genetic aspects of venous malformations helps families understand recurrence risks. While most venous malformations result from spontaneous mutations that occur during early development and are not inherited, certain subtypes (such as those associated with TIE2 mutations) can run in families. Genetic counseling may be recommended for patients with family histories of vascular malformations or those planning to have children^[2].

Maintaining overall health through balanced nutrition, appropriate exercise, and avoiding tobacco can support vascular health generally. While these lifestyle measures do not directly treat venous malformations, they contribute to better circulation and may help manage symptoms. Patients should discuss safe physical activities with their medical team, as certain sports or exercises might need modification depending on the malformation’s location^[18].